What is Enovis's licensing arrangements?

Enovis (ENOV) reported licensing arrangements of $4.98M in Q1 2026.

How has Enovis's licensing arrangements changed year-over-year?

Enovis's licensing arrangements increased by 185.0% year-over-year, from $1.75M to $4.98M.

What is the long-term trend for Enovis's licensing arrangements?

Over 4 years (2021 to 2025), Enovis's licensing arrangements has grown at a -0.3% compound annual growth rate (CAGR), from $5.05M to $4.99M.

Enovis ENOV Licensing Arrangements

Licensing Arrangements at other companies

Globus MedicalGMED

——

Other financials

Income statement

See full

Revenue$589.2M+5.4%

Gross profit$365.5M+10.0%

Operating income$6.5M+114%

Net income-$8.8M+84.3%

EPS (diluted)-$0.15+84.7%

Balance sheet

See full

Cash & equivalents$33.1M-13.9%

Total debt$1.4B-3.1%

Total equity$1.5B-43.6%

Total assets$3.8B-21.4%

Cash flow

See full

Operating cash flow$24.0M+1,601%

CapEx$52.8M+22.1%

Free cash flow-$28.9M+35.7%

Valuation

See full

Market cap$1.23B-28.4%

Enterprise value$2.55B-17.1%

P/S0.5×-0.3×

Profitability

See full

Gross margin60.5%+4.0pp

Operating margin-47%+18.6pp

Net margin-49.9%+24.1pp

FCF margin-3.1%-1.1pp

Returns & leverage

See full

Return on equity-55.5%-1,722pp

Debt / equity0.9×+0.4×

Current ratio2×-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:AccruedRoyaltiesCurrent.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's licensing arrangements.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Enovis's licensing arrangements?: Enovis (ENOV) reported licensing arrangements of $4.98M in Q1 2026.
How has Enovis's licensing arrangements changed year-over-year?: Enovis's licensing arrangements increased by 185.0% year-over-year, from $1.75M to $4.98M.
What is the long-term trend for Enovis's licensing arrangements?: Over 4 years (2021 to 2025), Enovis's licensing arrangements has grown at a -0.3% compound annual growth rate (CAGR), from $5.05M to $4.99M.